Wann Ist Bei Hypertonie-Patienten Eine Echokardiographie Nötig?
Summary
Take-home Message
Funding / potential competing interests
References
- Levy, D.; Garrison, R.J.; Savage, D.D.; Kannel, W.B.; Castelli, W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990, 322, 1561–1566. [Google Scholar] [CrossRef] [PubMed]
- Gardin, J.M.; Wagenknecht, L.E.; Anton-Culver, H.; Flack, J.; Gidding, S.; Kurosaki, T.; et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation. 1995, 92, 380–387. [Google Scholar] [CrossRef] [PubMed]
- Lieb, W.; Xanthakis, V.; Sullivan, L.M.; Aragam, J.; Pencina, M.J.; Larson, M.G.; et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of shortand long-term change in the framingham offspring study. Circulation. 2009, 119, 3085–3092. [Google Scholar] [CrossRef] [PubMed]
- Conen, D.; Zeller, A.; Pfisterer, M.; Martina, B. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol. 2006, 97, 249–252. [Google Scholar] [CrossRef] [PubMed]
- Mancia, G.; De Backer, G.; Dominiczak, A.; Cifkova, R.; Fagard, R.; Germano, G.; et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007, 25, 1105–1187. [Google Scholar] [CrossRef] [PubMed]
- Dahlof, B.; Pennert, K.; Hansson, L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens. 1992, 5, 95–110. [Google Scholar] [CrossRef] [PubMed]
- Verdecchia, P.; Staessen, J.A.; Angeli, F.; de Simone, G.; Achilli, A.; Ganau, A.; et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009, 374, 525–533. [Google Scholar] [CrossRef] [PubMed]
- Levy, D.; Larson, M.G.; Vasan, R.S.; Kannel, W.B.; Ho, K.K. The progression from hypertension to congestive heart failure. JAMA. 1996, 275, 1557–1562. [Google Scholar] [CrossRef] [PubMed]
- Conen, D.; Tedrow, U.B.; Koplan, B.A.; Glynn, R.J.; Buring, J.E.; Albert, C.M. Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women. Circulation. 2009, 119, 2146–2152. [Google Scholar] [CrossRef] [PubMed]
- Camm, A.J.; Kirchhof, P.; Lip, G.Y.; Schotten, U.; Savelieva, I.; Ernst, S.; et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010, 31, 2369–2429. [Google Scholar] [PubMed]
© 2014 by the author. Attribution - Non-Commercial - NoDerivatives 4.0.
Share and Cite
Conen, D. Wann Ist Bei Hypertonie-Patienten Eine Echokardiographie Nötig? Cardiovasc. Med. 2014, 17, 40. https://doi.org/10.4414/cvm.2014.00210
Conen D. Wann Ist Bei Hypertonie-Patienten Eine Echokardiographie Nötig? Cardiovascular Medicine. 2014; 17(2):40. https://doi.org/10.4414/cvm.2014.00210
Chicago/Turabian StyleConen, David. 2014. "Wann Ist Bei Hypertonie-Patienten Eine Echokardiographie Nötig?" Cardiovascular Medicine 17, no. 2: 40. https://doi.org/10.4414/cvm.2014.00210
APA StyleConen, D. (2014). Wann Ist Bei Hypertonie-Patienten Eine Echokardiographie Nötig? Cardiovascular Medicine, 17(2), 40. https://doi.org/10.4414/cvm.2014.00210